Constitutive activation of Stat3 signaling confers resistance to apoptosisin human U266 myeloma cells

Citation
R. Catlett-falcone et al., Constitutive activation of Stat3 signaling confers resistance to apoptosisin human U266 myeloma cells, IMMUNITY, 10(1), 1999, pp. 105-115
Citations number
56
Categorie Soggetti
Immunology
Journal title
IMMUNITY
ISSN journal
10747613 → ACNP
Volume
10
Issue
1
Year of publication
1999
Pages
105 - 115
Database
ISI
SICI code
1074-7613(199901)10:1<105:CAOSSC>2.0.ZU;2-H
Abstract
Interleukin 6 (IL-6) is the major survival factor for myeloma tumor cells a nd induces signaling through the STAT proteins. We report that one STAT fam ily member, Stat3 is constitutively activated in bone marrow mononuclear ce lls from patients with multiple myeloma and in the IL-6-dependent human mye loma cell line U266, Moreover, U266 cells are inherently resistant to Fas-m ediated apoptosis and express high levels of the antiapoptotic protein Bcl- x(L). Blocking IL-6 receptor signaling from Janus kinases to the Stat3 prot ein inhibits Bcl-x(L) expression and induces apoptosis, demonstrating that Stat3 signaling is essential for the survival of myeloma tumor cells. These findings provide evidence that constitutively activated Stat3 signaling co ntributes to the pathogenesis of multiple myeloma by preventing apoptosis.